S, M., S, A., J, C., B, H., & M, G. (2025). Exacerbation of Crohn's Disease Following Exposure to Anti-OX40 Monoclonal Antibody Therapy. ACG case reports journal, 12(8), e01810. https://doi.org/10.14309/crj.0000000000001810
Chicago Style (17th ed.) CitationS, MacKay, Alhaidari S, Cooper J, Halloran B, and Gozdzik M. "Exacerbation of Crohn's Disease Following Exposure to Anti-OX40 Monoclonal Antibody Therapy." ACG Case Reports Journal 12, no. 8 (2025): e01810. https://doi.org/10.14309/crj.0000000000001810.
MLA (9th ed.) CitationS, MacKay, et al. "Exacerbation of Crohn's Disease Following Exposure to Anti-OX40 Monoclonal Antibody Therapy." ACG Case Reports Journal, vol. 12, no. 8, 2025, p. e01810, https://doi.org/10.14309/crj.0000000000001810.